chrisvoncsefalvay/vaers-outcomes huggingface dataset:
unexpected benefit of the Pfizer COVID-19 BNT162b2 vaccine; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient reported for herself). A 73-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9264; Expiration Date: May2021), first dose via an unspecified route of administration on 09Feb2021 (at the age of A 73-year-old) as dose 1, single for COVID-19 immunisation. Medical history included cough from 26Nov2020 to 09Feb2021, sinusitis from an unknown date and unknown if ongoing and always had had sinus issues that resulted in more postnasal drainage. The patient's concomitant medications were not reported. On an unspecified date in 2021, the patient experienced unexpected benefit of the Pfizer covid-19 bnt162b2 vaccine. It was reported that, wanted to let you know there may be a serendipitous benefit to your vaccine that you can make use of to cure upper respiratory conditions. And said this in all seriousness because it cured her. Starting 3 months ago, right around Thanksgiving, she developed a very significant upper respiratory cough. She always had had sinus issues that resulted in more postnasal drainage than most people, and it was around the same time she turned on her house's heating system, and found her whole house humidifier had stopped working, Because of COVID, she did not want HVAC workers in the house, so she figured she should live without the humidifier this winter. The heat was extremely dry, and she assumed that the dryness, plus her chronic sinus issue and intermittent reflux was making her cough a lot. It seemed to come from the throat, and never from the chest. This continued every day from Thanksgiving till 09Feb2021, without any other symptoms. It did not seem to get any better or any worse, but for 2.5 months she was coughing so much on the phone with people that they were always telling her she must have Covid. But she had no other symptoms at all. Then, on 09Feb2021, I had my first Pfizer Covid vaccination, and miraculously, a couple of days later the coughing completely stopped. It did not taper down over several days; it just stopped. It was now 12 days since her shot and her cough has not returned. So, in addition to thanking, you for the vaccine, she wants to add her very sincere gratitude for stopping her cough. she thought you might not know about this benefit, but perhaps there was something in the vaccine that she stumbled on that could be isolated and used to treat coughs or other upper respiratory conditions. She had no symptoms after the shot and was scheduled for the second dose on 02Mar2021 at PRIVACY where she also had the first one. The outcome of the event was reported as unknown.  No follow-up attempts are needed. No further information is expected.
Broke out in a rash on neck and torso.  Body aches and headache as well.  Treated with Benadryl and Prednisone
Left arm red, grapefruit size area, slight itching, not warm to touch. Treatment with cool compresses, Benadryl and Tylenol.
The medical facility did not treat patient as her primary care, but were informed that she passed away on 15 February 2021 of a stroke.  I do not have further information on the medical aspect of this as we were not her treating provider but did administer the vaccine on 12 February.
Hives, extreme dizziness, weakness, headache, hives, nausea, rapid hearbeat, chest pressure, shortness of breath, sweating, throat tightness.  Admitted to emergency room at Hospital.
This spontaneous report was received from a pharmacist referring to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not reported. It was reported that, on unspecified dates since August 2016, the patients were vaccinated with improperly stored doses of VARIVAX lot # M023384 with expiration date of 11-MAY-2018, for prophylaxis (dose, route, anatomical location and frequency were not reported). The sterile diluent (manufacturer unknown) used to reconstitute the VARIVAX was properly stored, but the pharmacist was not sure which sterile diluent lot numbers were used to reconstitute VARIVAX, but one of the lot numbers was possibly M046371 with expiration date 07/06/2019.  No symptoms were reported. It was stated that the vaccines underwent a temperature excursion of 34.52 degrees Fahrenheit for 7 hours and 34 degrees Fahrenheit for 2 hours and 15 minutes. No previous temperature excursion was done. The call was not because of a "data logger". No further information was provided. Additional information is not expected because there is no consent to contact the reporter.
This spontaneous report as received from a pharmacy intern refers a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history, any known allergies or reactions or concomitant medications. On an unknown date in April 2017 (reported as last week), the patient was inadvertently vaccinated with a dose of VARIVAX, for prophylaxis (dose, route of administration, lot number and expiration date were not reported), instead of ZOSTAVAX. No adverse effects were reported. No further information provided. No product quality complaint was involved. Additional information has been requested.
Patient woke up with a purple petechial rash on his left lower arm approximately 24 hours after receiving Menactra vaccine in his left upper arm - seen by dermatologist who thought it hypersensitivity reaction.
Immediately after immunization developed hives at site of shots and developed scattered urticaria over entire body.
Patient received her bivalent booster on 9/15/22. She felt fatigued the following day which she expected but it continued to get worse. She started to get short of breath a day or two prior to becoming very dizzy. The day she became dizzy (9/27/22), she went to the ER where they discovered she had multiple pulmonary emboli. The patient is now taking Eliquis.
Vomited x1 after leaving appointment. Fell asleep and upon waking became fussy. Mom gave patient TYLENOL (first dose ever given). Patient vomited up TYLENOL. Patient began trembling x 1-2 minutes, with abnormal eye movement. Patient then brought to clinic.
diagnosed with COVID-19; never received the second dose; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (diagnosed with COVID-19) and PRODUCT DOSE OMISSION ISSUE (never received the second dose) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Dec-2020, the patient experienced PRODUCT DOSE OMISSION ISSUE (never received the second dose). On an unknown date, the patient experienced COVID-19 (diagnosed with COVID-19). At the time of the report, COVID-19 (diagnosed with COVID-19) and PRODUCT DOSE OMISSION ISSUE (never received the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
Although it was refrigerated, it has been out of the freezer 41 days; No adverse event; Vial was taken out of the freezer June 8th and placed in refrigerator. Vaccine was administered 19-Jul-2023; Patient received MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) as first dose; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vial was taken out of the freezer June 8th and placed in refrigerator. Vaccine was administered 19-Jul-2023), WRONG PRODUCT ADMINISTERED (Patient received MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) as first dose), PRODUCT STORAGE ERROR (Although it was refrigerated, it has been out of the freezer 41 days) and NO ADVERSE EVENT (No adverse event) in a 38-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7180B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Jul-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Jul-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vial was taken out of the freezer June 8th and placed in refrigerator. Vaccine was administered 19-Jul-2023) and WRONG PRODUCT ADMINISTERED (Patient received MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) as first dose). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Although it was refrigerated, it has been out of the freezer 41 days) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vial was taken out of the freezer June 8th and placed in refrigerator. Vaccine was administered 19-Jul-2023), WRONG PRODUCT ADMINISTERED (Patient received MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) as first dose), PRODUCT STORAGE ERROR (Although it was refrigerated, it has been out of the freezer 41 days) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Vial was taken out of the freezer June 8th and placed in refrigerator. Vaccine was administered 19-Jul-2023), WRONG PRODUCT ADMINISTERED (Patient received MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) as first dose) and PRODUCT STORAGE ERROR (Although it was refrigerated, it has been out of the freezer 41 days).    No concomitant information was reported. No treatment information was provided.
After my first injection on 04/01/2021 with the hour my arm got red with a knot. Very painful by the next day it went from the size of a quarter to the size of a 50 cent piece. It stayed for 4 days and was only itchy on the last day. My second was the same within a hour, the difference was started the size of a 50 cent piece, hurt worse but the infection site is hot to the touch. My arm is swollen, red and hot on injection site. It has been 3 days now and I just took a picture. Felt dizzie for about 15 minutes twice today and a little nausea but again very hot only where the injection went in.
Patient felt faint, dizzy and hot. She stated she hadn't eaten or drank anything prior to vaccination. BP: 128/78; pulse: 80. She was given water and a snack. She was asked to remain for an additional 15 minutes. Her daughter was also present, and indicated she thinks she was having a panic attack. Patient's blood pressure again taken (15 mins later). BP: 118/70; pulse: 68. Patient stated she felt fine prior to her departure.
Started 12/28/10 with a lump on (L) thigh. Then developed 2 more vesicles & a fever starting 12/30.
LIGHT HEADEDNESS, THEN SEIZURE FOR ABOUT 10 SECONDS. WE CAUGHT PATIENT AND LIED HIM ON THE FLOOR AND TURNED PATIENT ON A SIDE, ARM WAS SWELLING AND TURNED ORANGE. PATIENT WAS CONCIOUS, EMT ARRIVED AND TOOK HIM TO THE HOSPITAL.
On 12-2-22 patient received 0.2ml of covid 19 pfizer toddler age 3-4 without diluent of 2.2 ml  this was his seccond dose  Parent said did run   a high fever at around 2:30am the morning of 12-3-22 and motrin/tylenol did bring fever down. As of the early morning of 12-3-22 patient was doing better per father. Pediatrician was contacted on 12-2-22 and did call parents and posion control and decided to just watch for adverse effects and report any to them if occur. Following up with Pfizer on 12-5-22
BODY ACHES; INNER GROIN PAIN; LEG TENDERNESS CAUSE TROUBLE IN WALKING FELT ARTHRITIC AND CALF PAIN; SEVERE HEADACHE; This spontaneous report received from a patient concerned a 53 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non alcohol user, and non smoker, and other pre-existing medical conditions included no known allergies and had no drug abuse or illicit drug usage. The patient did not experienced any pain prior to vaccine.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 08-APR-2021 15:17 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-APR-2021, the subject experienced body aches. On 09-APR-2021, the subject experienced inner groin pain. On 09-APR-2021, the subject experienced leg tenderness cause trouble in walking felt arthritic and calf pain. On 09-APR-2021, the subject experienced severe headache. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from severe headache on 10-APR-2021, and had not recovered from body aches, leg tenderness cause trouble in walking felt arthritic and calf pain, and inner groin pain. This report was non-serious.
This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 06Aug2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 16Jul2021 as dose 1, single for covid-19 immunisation. On unspecified date, the patient experienced enlarged lymph glands and that are really painful. The outcome of the events was unknown. Information about lot/batch number has been requested.
This spontaneous report was received from a physician via field representative posted on the website, refers to a female patient of unknown age. The patient's medical history, concurrent conditions and medical history were unknown by reporter. The article on the website stated a rare warning against GARDASIL injection due to reports of premature ovarian failure. The article also mentioned that one country has halted use of GARDASIL due to fertility concerns. The outcome of the events was unknown. Causality assessment was not provided. No product quality complaint (PQC) was involved. No further information provided. Additional information has been requested.
worse at night; trouble sleeping; could hear her heartbeat in her head, and it "would drive her nuts"; palpitations scare her; palpitations; usual sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (palpitations), PALPITATIONS (worse at night), PAIN IN EXTREMITY (usual sore arm), INSOMNIA (trouble sleeping) and PULSE ABNORMAL (could hear her heartbeat in her head, and it "would drive her nuts") in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Low blood pressure and GERD. Concurrent medical conditions included Sulfonamide allergy and Food allergy (Crab meat allergy).    On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (usual sore arm). On 25-Feb-2021, the patient experienced PALPITATIONS (palpitations), INSOMNIA (trouble sleeping), PULSE ABNORMAL (could hear her heartbeat in her head, and it "would drive her nuts") and FEAR OF DISEASE (palpitations scare her). On an unknown date, the patient experienced PALPITATIONS (worse at night). At the time of the report, PALPITATIONS (palpitations), PALPITATIONS (worse at night), PAIN IN EXTREMITY (usual sore arm), INSOMNIA (trouble sleeping), PULSE ABNORMAL (could hear her heartbeat in her head, and it "would drive her nuts") and FEAR OF DISEASE (palpitations scare her) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided   This case was linked to MOD-2021-049358 (Patient Link).
Unusual monthly period/bright red blood/Numerous & large blood clots; This is a spontaneous report from a contactable consumer (patient). This non-pregnant 46-year-old female (patient) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number ER8737) via an unknown route of administration in the left arm on 02Apr2021 at 10:45 (at 46-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to sulfa from an unknown date. Concomitant medications were not reported. Prior to vaccination the patient had not been diagnosed with COVID-19 and had not received any other vaccines in 4 weeks. On 02Apr2021 at 11:00 the patient experienced unusual monthly period, numerous and large blood clots, and bright red blood. The patient received no treatment for the events. The clinical outcome of the event was recovered in Apr2021. Since vaccination the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Syncope episode after getting up from toilet. Hit head as a result of falling. Found face down, turning purple, jerky movements. Nausea and vomiting after regaining consciousness. Had not eaten anything yet that day. Have a history of vasovagal syncope episodes, but usually can feel them coming on and lie down. This episode struck suddenly without warning. The previous night was very fatigued presumably from vaccine. No headache, no neck pain, no vision issues, no weakness, no chest pain, no shortness of breath. Menustrating.
Swollen and painful lymph node near collarbone; Swollen and painful lymph node near collarbone; Achy joints; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 22Apr2021 at 14:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies and sports induced asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 01Apr2021 at 15:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 07:30, the patient experienced swollen and painful lymph node near collarbone and achy joints. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen and painful lymph node near collarbone and achy joints were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
This case was reported by a healthcare professional and described the occurrence of local reaction at injection site in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of FLUARIX in an unknown deltoid. Within one day of vaccination, the subject experienced a local reaction at the injection site with injection site redness and injection site pain. Drowsiness was also reported. At the time of reporting the outcome of the events was unspecified. The nurse reported that 7 employees of the nursing home received FLUARIX and experienced a local injection site reaction within one day from vaccination. The local reactions ranged from local redness and pain at the injection site to left arm pain which radiated to the chest in one subject and left arm pain which radiated down the arm in another subject. No additional information was provided at the time of reporting. Linked case numbers include A0809357A through A0809362A.
This spontaneous report as received from a healthcare student refers to a patient of unknown age and gender. The patient's medical history and concurrent condition were not reported. On 31-MAY-2016 the patient was vaccinated with ZOSTAVAX (Lot# L046897, Expiration date 23-FEB-2017, route and dose not reported). Concomitant therapy was not reported. The ZOSTAVAX was improperly stored under 16 Fahrenheit degree for 19 hours. No previous temperature excursion. Data logger was not involved. No adverse events reported. Additional information has been requested.
pt recv vax 12OCT96 & 8 days later pt exp a gen maculopapular rash, mainly on the trunk & scattered on the face & extremities;pt was seen by MD 23OCT96 & recovered by 27OCT96;
After receiving the flu shot my arm got sore beyond the normal tenderness of getting a vaccine. I felt as though I had been hit in my arm with a hard object. There was no swelling, redness or heat. It was not a bad reaction to the vaccine itself but the way it was administered. I let a few days go by thinking maybe it would getting better as people assured me some soreness was ok. This wasn't like a normal soreness though. As the days passed the pain got worse. I was unable to get clothes on and off, brush my hair or so any other motion that required me to lift my arm. The should joint ached and my mobility was limited. After weeks of this pain getting worse and not better I address with with my chiropractor who looked at it and then made an appointment with my general physician to have it looked at.
FALLS, CHEST PAIN, HEMORRAHAGIC CONTUSION, COVID, PNEUMONIA, HYPOXIC RESPIRATORY FAILURE Narrative:  2/22/2021 Patient presented to hospital with multiple complaints. He was reporting falls, chest pain, his wife was diagnosed with Covid. While he was there, he was found to have hemorrhagic contusion in the right frontoparietal region with minimal surrounding edema, Covid, pneumonia, elevated troponin. He was accepted in transfer by trauma surgeon Dr. and arrives with no complaints. 2/26/2021 Patient died after code blue was called Death Diagnosis: s/p fall with head trauma Focal area right intracranial hemorrhage per initial CT - serial CT head showing stability Acute hypoxic respiratory failure secondary to COVID-19 viral illness COVID-19 viral illness Acute chest pain, improved Elevated troponin, suspected type 2 NSTEMI Elevated D-dimer - V/Q scan with intermittent probability PE Acute kidney injury on CKD, improving unlikely that vaccine contributed to patient's death.